Summary
62 / 100 · Bulios Score
What speaks for it
- Out of every 100 CNY of revenue, 17 CNY is left as net profit.
- It holds more cash than debt: ¥571.5M against ¥39.5M.
What to watch
- Revenue fell by 5.7% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 38.3 CNY for 1 CNY of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (CNY)
Diluted EPS (CNY)
- Analyst estimate
Revenue grew by 1.6% a year over 5 years. Over the last 3 years it fell by 5.7% a year. Earnings per share fell by 9.5% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 CNY of revenue goes
- Cost of sales 66 CNY
- Research and development 5.2 CNY
- Sales and administration 11 CNY
- Taxes and other 1.3 CNY
- Net profit 17 CNY
Net profit, industry median (Chemicals) 4.5 CNY
Out of every 100 CNY of revenue, 17 CNY is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail